Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 7, 1996, Pages 2448-2454

  O'Neal, D ^a,b   Hew, F L ^a,b   Sikaris, K ^b   Ward, G ^a,b   Alford, F ^a,b   Best, J D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; HYPOPITUITARISM; MALE; PARTICLE SIZE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPOPITUITARISM; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; TRIGLYCERIDES;

EID: 0029900206     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.7.2448     Document Type: Article

References (40)

1. Rosen T, Bengtsson B-A. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
2. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 340:1188-1192.
3. Wuster C, Slenczka E, Ziegler R. 1991 Erhohte pravalenz von osteoporose und arteriosklerose bei konventionell substituierter hypophysenvorderlappeninsuffizienz: bedarf einer zusatzlichen wachstumshormonsubstituttion? Klin Wochenschr. 69:769-773.
4. Beshyah SA, Henderson A, Nithyanathan R, Sharp P, Richmond W, Johnston DG. 1994 Metabolic abnormalities in growth hormone-deficient adults. II. Carbohydrate tolerance and lipid metabolism. Endocrinol Metab. 1:173-180.
5. Cuneo R, Salomon F, Watts GF, Hesp R, Sonksen PH. 1993 Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 42:1519-1523.
6. de Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA. 1994 Serum lipid levels in growth hormone-deficient men. Metabolism. 43:199-203.
7. Winter RJ, Thompson RG, Green OC. 1979 Serum cholesterol and triglycerides in children with growth hormone deficiency. Metabolism. 28:1244-1249.
8. Ishibashi S, Murase T, Yamada N, Tanake K, Sato K. 1985 Hyperlipidaemia in patients with hypopituitarism. Acta Endocrinol (Copenh). 110:456-460.
9. Heiss G, Tamir I, Davis CE, et al. 1980 Lipoprotein cholesterol distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation. 61:302-315.
10. Shen MM, Krauss RM, Lindgren FT, Forte TM. 1981 Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res. 22:236-244.
11. Krauss RM, Burke DJ. 1982 Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 23:97-104.
12. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. 1988 Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 260:1917-1921.
13. Austin MA, King M-C, Vranizan KM, Krauss RM. 1990 Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 82:495-506.
14. Cuneo RC, Salomen F, McGauley GA, Sonksen PH. 1992 The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 37:387-397.
15. O'Neal DN, Kalfas A, Dunning PL, et al. 1994 The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. J Clin Endocrinol Metab. 79:975-983.
16. Hew FL, Koschmann M, Krieger T, et al. 1995 Insulin tolerance test in patients with anterior pituitary hormone deficiency: reduced insulin sensitivity. Endocrinol Metab. 2:93-98.
17. Lohman TG, Roche AF, Martorell R. 1980 Anthropometric standardization reference manual. Champaign: Human Kinetic Books.
18. Hew FL, Koschmann M, Christopher M, et al. 1996 Insulin resistance in growth hormone deficient adults: defects in glucose utilisation and glycogen synthase activity. J Clin Endocrinol Metab. 81:555-564.
19. Albano JR, Ekins G, Martz G, Turner R. 1972 A sensitive precise radioim-munoassay of serum insulin based on a charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) 70:487-509.
20. Goldstein DE, Weidmeyer HM, England JD, Little RR, Parker KM. 1984 Recent advances in glycosylated haemoglobin measurements. Crit Rev Clin Lab Sci. 21:187-228.
21. O'Neal DN, Lee P, Murphy B, Best JD. 1996 Low density lipoprotein particle size distribution in end stage renal disease treated with hemodialysis or peritoneal dialysis. Am J Kidney Dis. 27:84-91.
22. Chung BH, Segrest JP, Ray MJ, et al. 1986 Single vertical spin density gradient ultracentrifugation. In: Segrest JP, Albers JJ, eds. Methods in enzymology, chapt 8. New York: Academic Press; 181-209.
23. Crouse JR, Parks JS, Schey HM, Kahl FR. 1985 Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 26:566-574.
24. Haffner SM, Mykkanen L, Stern M, Paidi M, Howard BV. 1994 Greater effect of diabetes on LDL size in women than men. Diabetes Care. 17:1164-1171.
25. Garcia MJ, McNamara PM, Gordon T, Kannel WB. 1974 Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up. Diabetes. 23:105-111.
26. Barrett-Connor E, Wingard DL. 1983 Sex difference in ischemic heart disease mortality in diabetics: a prospective population based study. Am J Epidemiol. 118:489-496.
27. Sonksen PH, Salomen F, Cuneo R. 1991 Metabolic effects of hypopituitarism and acromegaly. Horm Res. 33(Suppl 4):19-24.
28. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. 1993 Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest. 92:141-146.
29. Reaven GM. 1988 Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
30. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. 1991 Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 3:416-422.
31. Job JC. 1981 The pituitary. In: Job PC, Pierson M, eds. Pediatric endocrinology. New York: Wiley and Sons; 85-160.
32. Loeb JN. 1986 Thyroid diseases: disorders that cause hypothyroidism- metabolic changes. In: Ingbar SH, Braverman LE, eds. Werner's, the thyroid-a fundamental and clinical text, 5th ed. Philadelphia: Lipincott; 1208-1209.
33. Wallace RB, Hoover J, Barrett-Connor E, et al. 1979 Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Lancet. 2:111-115.
34. Stefanick ML, Williams PT, Krauss RM, Terry RB, Vranizan RM, Wood PD. 1987 Relationships of plasma estradiol, testosterone, and sex hormone binding globulin with lipoproteins, apolipoproteins, and high density lipoprotein sub-fractions in men. J Clin Endocrinol Metab. 64:723-729.
35. Campos H, Sacks FM, Walsh BW, Schiff I, O'Hanesian MA, Krauss RM. 1993 Differential effects of estrogen on low density lipoprotein subclasses in healthy postmenopausal women. Metabolism. 42:1153-1158.
36. Jones DB, Higgins B, Billet JS, et al. 1989 The effect of testosterone replacement on plasma lipids and apolipoproteins. Eur J Clin Invest. 19:438-441.
37. Salomen F, Cuneo RC, Hesp R, Sonksen P. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
38. Blomhoff JP. 1992 Lipoproteins, lipases, and the metabolic cardiovascular syndrome. J Cardiovasc Pharmacol. 20(Suppl 8):S22-S25.
39. Tall AR. 1993 Plasma cholesteryl ester transfer protein. J Lipid Res. 34:1255-1274.
40. Coresh J, Kwiterovitch PO, Smith HH, Bachorik PS. 1993 Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 34:1687-1697.